1-20 of 31 results for subject:Misuse
Librarians' tools
- Search time
- 0.243 seconds
- Solr query time
- 0.008 seconds
- Search query
- subject:Misuse
- We searched for
- subject_t:Misuse OR subject_t:"Substance misuse" OR subject_ses:92056
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
Legislative stage
Legislation
Subject
More
Publisher
Clauses 11 to 62 agreed to, with clauses 11, 23, 27, 35, 38, 39, 42, 47, 49, 50, 53, 54 and 58 agreed to as amended. Schedules 2 to 4 agreed to, with schedules 2 and 4 agreed to as amended. Clause 57 discussed with new clause 4 (New psychoactive substances: prevention and education). New clause 2 (Possession of a psychoactive substance in a custodial institution) agreed to. New clause 3 (Exceptions to offences) agreed to. New clause 1 (Breach of a premises notice) debated and withdrawn. New schedule 1 (Exempted activities) agreed to. Written evidence reported to the House. Bill, as amended, to be reported (Bill 88).
Clauses 11 to 62 agreed to, with clauses 11, 23, 27, 35, 38, 39, 42, 47, 49, 50, 53, 54 and 58 agreed to as amended. Schedules 2 to 4 agreed to, with schedules 2 and 4 agreed to as amended. Clause 57 discussed with new clause 4 (New psychoactive...
Programme motion agreed to. Written evidence (Reporting to the House) motion agreed to. Clauses 1 to 3 agreed to, with clause 1 agreed to as amended. Clause 1 discussed with Government new clause 2 (Possession of a psychoactive substance in a custodial institution), Government new clause 3 (Exceptions to offences) and Government new schedule 1 (Exempted activities). Schedule 1 under consideration.
Programme motion agreed to. Written evidence (Reporting to the House) motion agreed to. Clauses 1 to 3 agreed to, with clause 1 agreed to as amended. Clause 1 discussed with Government new clause 2 (Possession of a psychoactive substance in a custodial institution), Government new clause 3 (Exceptions to offences)...
Schedule 1 agreed to as amended. Clauses 4 to 9 agreed to as amended. Motion to transfer agreed to. Clause 10 disagreed to.
Schedule 1 agreed to as amended. Clauses 4 to 9 agreed to as amended. Motion to transfer agreed to. Clause 10 disagreed to.
Second reading. Debate adjourned. Motion to proceed with the second reading until midnight. Agreed to on question. Debate resumed. Second reading agreed to on question. Programme motion. Agreed to on question.
Second reading. Debate adjourned. Motion to proceed with the second reading until midnight. Agreed to on question. Debate resumed. Second reading agreed to on question. Programme motion. Agreed to on question.
Motion to consider. Agreed to on question.
Motion to consider. Agreed to on question.
Drug offending is serious in itself and drug abuse also underlies a huge volume of acquisitive and violent crime which can blight communities. Previous convictions, where they are recent and relevant, must be treated as an aggravating factor by the courts and will make the sentence more severe. The independent...
Drug offending is serious in itself and drug abuse also underlies a huge volume of acquisitive and violent crime which can blight communities. Previous convictions, where they are recent and relevant, must be treated as an aggravating factor by the courts and will make the sentence more severe. The independent...
To ask the Secretary of State for Health how much funding has been provided to people resident in Hemel Hempstead by the National Treatment Agency in each of the last five years; and how much has been allocated in the next two years.
To ask the Secretary of State for Health how much funding has been provided to people resident in Hemel Hempstead by the National Treatment Agency in each of the last five years; and how much has been allocated in the next two years.
| Funding (£) | |
| 2005-06 | 4,120,026 |
| 2006-07 | 4,933,918 |
| 2007-08 | 5,025,733 |
| 2008-09 | 4,961,579 |
| 2009-10 | 4,976,990 |
To ask the Secretary of State for Health how many people over the age of 50 years have been diagnosed with alcoholism in (a) Hemel Hempstead and (b) Hertfordshire in each of the last five years.
To ask the Secretary of State for Health how many people over the age of 50 years have been diagnosed with alcoholism in (a) Hemel Hempstead and (b) Hertfordshire in each of the last five years.
To ask the Secretary of State for the Home Department which schemes have received funding under the Communities Against Drugs Initiative in the Hemel Hempstead constituency in each year since 1997; how much was received under each scheme; and what targets were set relating to crime reduction under each scheme.
To ask the Secretary of State for the Home Department which schemes have received funding under the Communities Against Drugs Initiative in the Hemel Hempstead constituency in each year since 1997; how much was received under each scheme; and what targets were set relating to crime reduction under each scheme.
To ask the Secretary of State for Health how many people undergoing NHS alcohol treatment courses in (a) Hemel Hempstead and (b) Hertfordshire (i) have and (ii) have not completed the treatment successfully in each of the last five years.
To ask the Secretary of State for Health how many people undergoing NHS alcohol treatment courses in (a) Hemel Hempstead and (b) Hertfordshire (i) have and (ii) have not completed the treatment successfully in each of the last five years.
To ask the Secretary of State for Health how many people aged 11 to 18 years resident in (a) Hemel Hempstead and (b) Hertfordshire were treated for alcohol-related problems in each of the last five years.
To ask the Secretary of State for Health how many people aged 11 to 18 years resident in (a) Hemel Hempstead and (b) Hertfordshire were treated for alcohol-related problems in each of the last five years.
| Number of alcohol-related finished admissions for patients aged 11 to 18 resident in Hertfordshire | |||||
| PCT | 2002-03 | 2003-04 | 2004-05 | 2005-06 | 2006-07 |
| East and North Hertfordshire | 104 | 94 | 104 | 99 | 102 |
| West Hertfordshire | 107 | 110 | 114 | 82 | 122 |
| Notes: | |||||
| Includes activity in English national health service hospitals and English NHS commissioned activity in the independent sector. | |||||
| Small numbers | |||||
| To protect patient confidentiality, figures between 1 and 5 have been suppressed and replaced with ““*”” (an asterisk). Where it was possible to identify numbers from the total due to a single suppressed number in a row or column, an additional number (the next smallest) has been suppressed. | |||||
| Alcohol-related admissions | |||||
| The number of alcohol-related admissions is based on the methodology developed by the North West Public Health Observatory (NWPHO). Following international best practice, the NWPHO methodology includes a wide range of diseases and injuries in which alcohol plays a part and estimates the proportion of cases that are attributable to the consumption of alcohol. Details of the conditions and associated proportions can be found in the report Jones et al. (2008) ““Alcohol-attributable fractions for England: Alcohol-attributable mortality and hospital admissions””. | |||||
| Figures for under-16s only include admissions where one or more alcohol-specific conditions were listed. This is because the research on which the attributable fractions are based does not cover under-16s. Alcohol-specific conditions are those that are wholly attributed to alcohol—that is, those with an attributable fraction of one. They are: | |||||
| Alcoholic cardiomyopathy (142.6) | |||||
| Alcoholic gastritis (K29.2) | |||||
| Alcoholic myopathy (G72.1) | |||||
| Alcoholic polyneuropathy (G62.1) | |||||
| Alcohol-induced pseudo-Cushing's syndrome (E24.4) | |||||
| Degeneration of nervous system due to alcohol (G31.2) | |||||
| Mental and behavioural disorders due to use of alcohol (F10) | |||||
| Accidental poisoning by and exposure to alcohol (X45) | |||||
| Ethanol poisoning (T51.0) | |||||
| Methanol poisoning (T51.1) | |||||
| Toxic effect of alcohol, unspecified (T51.9). | |||||
| Number of episodes in which the patient had an alcohol-related primary or secondary diagnosis | |||||
| These figures represent the number of episodes where an alcohol-related diagnosis was recorded in any of the 14 (seven prior to 2002-03) primary and secondary diagnosis fields in a Hospital Episode Statistics (HES) record. Each episode is only counted once in each count, even if an alcohol-related diagnosis is recorded in more than one diagnosis field of the record. | |||||
| Finished admission episodes | |||||
| A finished admission episode is the first period of in-patient care under one consultant within one health care provider. Finished admission episodes are counted against the year in which the admission episode finishes. Admissions do not represent the number of in-patients, as a person may have more than one admission within the year. | |||||
| Primary diagnosis | |||||
| The primary diagnosis is the first of up to 14 (seven prior to 2002-03) diagnosis fields in HES data set and provides the main reason why the patient was in hospital. | |||||
| Secondary diagnoses | |||||
| As well as the primary diagnosis, there are up to 13 (six prior to 2002-03) secondary diagnosis fields in HES that show other diagnoses relevant to the episode of care. | |||||
| Data Quality | |||||
| HES are compiled from data sent by more than 300 NHS trusts and primary care trusts (PCTs) in England. Data is also received from a number of independent sector organisations for activity commissioned by the English NHS. The NHS Information Centre for health and social care liaises closely with these organisations to encourage submission of complete and valid data and seeks to minimise inaccuracies and the effect of missing and invalid data via HES processes. While this brings about improvement over time, some shortcomings remain. | |||||
| Source: | |||||
| Hospital Episode Statistics (HES), the NHS Information Centre for health and social care. |
To ask the Secretary of State for Health which trigger offences lead to drug testing as part of his Department's drug intervention programme; and whether he plans to include further offences within that definition.
To ask the Secretary of State for Health which trigger offences lead to drug testing as part of his Department's drug intervention programme; and whether he plans to include further offences within that definition.
To ask the Secretary of State for Health how many people residing in London are estimated to have used (a) Class A drugs and (b) any illegal drugs in the last year for which figures are available.
To ask the Secretary of State for Health how many people residing in London are estimated to have used (a) Class A drugs and (b) any illegal drugs in the last year for which figures are available.
To ask the Secretary of State for Health how many drugs-related hospital admissions were recorded in London in each of the last five years.
To ask the Secretary of State for Health how many drugs-related hospital admissions were recorded in London in each of the last five years.
| Number of total admissions | |
| 2006-07 | 25,782 |
| 2005-06 | 25,148 |
| 2004-05 | 21,938 |
| 2003-04 | 18,810 |
| 2002-03 | 16,069 |
| Notes: | |
| 1. Finished admission episodes: A finished admission episode is the first period of in-patient care under one consultant within one health care provider. Admissions do not represent the number of in-patients, as a person may have more than one admission within the year. | |
| 2. The ICD-10 codes used to identify a drug related diagnosis are as follows. It is not possible to identify in ICD-10 all diseases caused by drugs (legal or illegal) and there is no way to guarantee, that the admission was drug related. For example, a patient admitted for inguinal hernia surgery may also be dependent on a drug. | |
| F11—Mental and behavioural disorders due to use of opioids | |
| F12—Mental and behavioural disorders due to use of cannabinoids | |
| F13—Mental and behavioural disorders due to use of sedatives or hypnotics | |
| F14—Mental and behavioural disorders due to use of cocaine | |
| F15—Mental and behavioural disorders due to use of other stimulants, including caffeine | |
| F16—Mental and behavioural disorders due to use of hallucinogens | |
| F18—Mental and behavioural disorders due to use of volatile solvents | |
| F19—Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances | |
| F55—Abuse of non-dependence-producing substances | |
| K71.0—Toxic liver disease with cholestasis | |
| K71.1—Toxic liver disease with hepatic necrosis | |
| K71.2—Toxic liver disease with acute hepatitis | |
| K71.3—Toxic liver disease with chronic persistent hepatitis | |
| K71.4—Toxic liver disease with chronic lobular hepatitis | |
| K71.5—Toxic liver disease with chronic active hepatitis | |
| K71.6—Toxic liver disease with hepatitis, not elsewhere classified | |
| K71.7—Toxic liver disease with fibrosis and cirrhosis of liver | |
| K71.8—Toxic liver disease with other disorders of liver | |
| K71.9—Toxic liver disease, unspecified | |
| T36—Poisoning by systemic antibiotics | |
| T37—Poisoning by other systemic anti-infectives and antiparasitics | |
| T38—Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified | |
| T39—Poisoning by nonopioid analgesics, antipyretics and antirheumatics | |
| T40—Poisoning by narcotics and psychodysleptics (hallucinogens) | |
| T41—Poisoning by anaesthetics and therapeutic gases | |
| T42—Poisoning by antiepileptic, sedative-hypnotic and antiparkinsonism drugs | |
| T43—Poisoning by psychotropic drugs, not elsewhere classified | |
| T44—Poisoning by drugs primarily affecting the autonomic nervous system | |
| T45—Poisoning by primarily systemic and haematological agents, not elsewhere classified | |
| T46—Poisoning by agents primarily affecting the cardiovascular system | |
| T47—Poisoning by agents primarily affecting the gastrointestinal system | |
| T48—Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system | |
| T49—Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolaryngological and dental drugs | |
| T50—Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances | |
| T52—Toxic effect of organic solvents | |
| T53—Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons | |
| T54—Toxic effect of corrosive substances | |
| T55—Toxic effect of soaps and detergents | |
| T56—Toxic effect of metals | |
| T57—Toxic effect of other inorganic substances | |
| T58—Toxic effect of carbon monoxide | |
| T59—Toxic effect of other gases, fumes and vapours | |
| T60—Toxic effect of pesticides | |
| T61—Toxic effect of noxious substances eaten as seafood | |
| T62—Toxic effect of other noxious substances eaten as food | |
| T63—Toxic effect of contact with venomous animals | |
| T64—Toxic effect of aflatoxin and other mycotoxin food contaminants | |
| T65—Toxic effect of other and unspecified substances | |
| X40—Accidental poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics | |
| X41—Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified | |
| X42—Accidental poisoning by and exposure to narcotics and psychodysleptics (hallucinogens), not elsewhere classified | |
| X43—Accidental poisoning by and exposure to other drugs acting on the autonomic nervous system | |
| X44—Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances | |
| X46—Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours | |
| X47—Accidental poisoning by and exposure to other gases and vapours | |
| X48—Accidental poisoning by and exposure to pesticides | |
| X49—Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances | |
| X60—Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics | |
| X61—Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified | |
| X62—Intentional self-poisoning by and exposure to narcotics and psychodysleptics (hallucinogens), not elsewhere classified | |
| X63—Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system | |
| X64—Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances | |
| X66—Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours | |
| X67—Intentional self-poisoning by and exposure to other gases and vapours | |
| X68—Intentional self-poisoning by and exposure to pesticides | |
| X69—Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances | |
| Y40—Systemic antibiotics | |
| Y41—Other systemic anti-infectives and antiparasitics | |
| Y42—Hormones and their synthetic substitutes and antagonists, not elsewhere classified | |
| Y43—Primarily systemic agents | |
| Y44—Agents primarily affecting blood constituents | |
| Y45—Analgesics, antipyretics and anti-inflammatory drugs | |
| Y46—Antiepileptic and antiparkinsonism drugs | |
| Y47—Sedatives, hypnotics and antianxiety drugs | |
| Y48—Anaesthetics and therapeutic gases | |
| Y49—Psychotropic drugs, not elsewhere classified | |
| Y50—Central nervous system stimulants, not elsewhere classified | |
| Y51—Drugs primarily affecting the autonomic nervous system | |
| Y52—Agents primarily affecting the cardiovascular system | |
| Y53—Agents primarily affecting the gastrointestinal system | |
| Y54—Agents primarily affecting water-balance and mineral and uric acid metabolism | |
| Y55—Agents primarily acting on smooth and skeletal muscles and the respiratory system | |
| Y56—Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs | |
| Y57—Other and unspecified drugs and medicaments | |
| Y58—Bacterial vaccines | |
| Y59—Other and specified vaccines and biological substances | |
| T80.0—Air embolism following infusion, transfusion and therapeutic injection | |
| T80.1—Vascular complications following infusion, transfusion and therapeutic injection | |
| T80.2—Infections following infusion, transfusion and therapeutic injection | |
| T80.8—Other complications following infusion, transfusion and therapeutic injection | |
| T80.9—Unspecified complication following infusion, transfusion and therapeutic injection | |
| T88.0—Infection following immunisation | |
| T88.1—Other complications following immunisation, not elsewhere classified | |
| T88.2—Shock due to anaesthesia | |
| T88.3—Malignant hyperthermia due to anaesthesia | |
| T88.5—Other complications of anaesthesia | |
| T88.6—Anaphylactic shock due to adverse effect of correct drug or medicament properly administered | |
| T88.7—Unspecified adverse effect of drug or medicament | |
| Z71.5—Drug abuse counselling and surveillance | |
| T96.X—Sequelae of poisoning by drugs, medicaments and biological substances | |
| 3. London Strategic Health Authority of Treatment: In 2006-07 London as a whole was a strategic health authority (SHA). Pre 2006-07 London was made up of five SHAs. | |
| 2006-07: London SHA | |
| Pre 2006-07: North West London; North Central London; North East London; South East London; South West London | |
| 4. Ungrossed Data: Figures have not been adjusted for shortfalls in data (i.e. the data are ungrossed). | |
| Source: | |
| Hospital Episode Statistics, The NHS Information Centre for health and social care |
To ask the Secretary of State for Health how many problematic drugs users were estimated to be residing in London in the last year for which figures are available.
To ask the Secretary of State for Health how many problematic drugs users were estimated to be residing in London in the last year for which figures are available.
(2) what the criteria were for selecting those invited to attend the four regional consultation meetings on his Department’s policy consultation on alcohol strategy.
(2) what the criteria were for selecting those invited to attend the four regional consultation meetings on his Department’s policy consultation on alcohol strategy.
| Number | ||||
| Invited | Accepted | Attended | ||
| Bristol | Diverse groups | 33 | 2 | 2 |
| Enforcement and local authorities | 217 | 15 | 11 | |
| Health—NHS | 146 | 8 | 7 | |
| Health—other | 0 | 0 | 0 | |
| Manufacturers | 48 | 0 | 0 | |
| Off-trade | 39 | 1 | 0 | |
| On-trade | 208 | 9 | 1 | |
| Total | 691 | 35 | 21 | |
| Newcastle | Diverse groups | 36 | 3 | 3 |
| Enforcement and local authorities | 163 | 32 | 26 | |
| Health—NHS | 102 | 23 | 18 | |
| Health—other | 3 | 2 | 1 | |
| Manufacturers | 23 | 0 | 0 | |
| Off-trade | 28 | 0 | 0 | |
| On-trade | 110 | 0 | 0 | |
| Total | 465 | 60 | 48 | |
| Liverpool | Diverse groups | 19 | 5 | 2 |
| Enforcement and local authorities | 64 | 11 | 8 | |
| Health—NHS | 110 | 17 | 13 | |
| Health—other | 1 | 1 | 1 | |
| Manufacturers | 36 | 1 | 1 | |
| Off-trade | 25 | 0 | 0 | |
| On-trade | 141 | 5 | 0 | |
| Total | 396 | 40 | 25 | |
| London | Diverse groups | 74 | 8 | 8 |
| Enforcement and local authorities | 508 | 33 | 25 | |
| Health—NHS | 273 | 10 | 7 | |
| Health—other | 6 | 5 | 4 | |
| Manufacturers | 31 | 3 | 1 | |
| Off-trade | 30 | 2 | 0 | |
| On-trade | 118 | 4 | 2 | |
| Total | 1040 | 65 | 47 | |
| Totals | Diverse groups | 162 | 18 | 15 |
| Enforcement and local authorities | 952 | 91 | 70 | |
| Health—NHS | 631 | 58 | 45 | |
| Health—other | 10 | 8 | 6 | |
| Manufacturers | 138 | 4 | 2 | |
| Off-trade | 122 | 3 | 0 | |
| On-trade | 577 | 18 | 3 | |
| Total | 2,592 | 200 | 141 |
To ask the Secretary of State for Health (1) how many (a) national and (b) regional meetings were conducted during the course of his Department’s policy consultation on alcohol strategy; and who (i) was invited to and (ii) attended each;
To ask the Secretary of State for Health (1) how many (a) national and (b) regional meetings were conducted during the course of his Department’s policy consultation on alcohol strategy; and who (i) was invited to and (ii) attended each;
| Number | ||||
| Invited | Accepted | Attended | ||
| Bristol | Diverse groups | 33 | 2 | 2 |
| Enforcement and local authorities | 217 | 15 | 11 | |
| Health—NHS | 146 | 8 | 7 | |
| Health—other | 0 | 0 | 0 | |
| Manufacturers | 48 | 0 | 0 | |
| Off-trade | 39 | 1 | 0 | |
| On-trade | 208 | 9 | 1 | |
| Total | 691 | 35 | 21 | |
| Newcastle | Diverse groups | 36 | 3 | 3 |
| Enforcement and local authorities | 163 | 32 | 26 | |
| Health—NHS | 102 | 23 | 18 | |
| Health—other | 3 | 2 | 1 | |
| Manufacturers | 23 | 0 | 0 | |
| Off-trade | 28 | 0 | 0 | |
| On-trade | 110 | 0 | 0 | |
| Total | 465 | 60 | 48 | |
| Liverpool | Diverse groups | 19 | 5 | 2 |
| Enforcement and local authorities | 64 | 11 | 8 | |
| Health—NHS | 110 | 17 | 13 | |
| Health—other | 1 | 1 | 1 | |
| Manufacturers | 36 | 1 | 1 | |
| Off-trade | 25 | 0 | 0 | |
| On-trade | 141 | 5 | 0 | |
| Total | 396 | 40 | 25 | |
| London | Diverse groups | 74 | 8 | 8 |
| Enforcement and local authorities | 508 | 33 | 25 | |
| Health—NHS | 273 | 10 | 7 | |
| Health—other | 6 | 5 | 4 | |
| Manufacturers | 31 | 3 | 1 | |
| Off-trade | 30 | 2 | 0 | |
| On-trade | 118 | 4 | 2 | |
| Total | 1040 | 65 | 47 | |
| Totals | Diverse groups | 162 | 18 | 15 |
| Enforcement and local authorities | 952 | 91 | 70 | |
| Health—NHS | 631 | 58 | 45 | |
| Health—other | 10 | 8 | 6 | |
| Manufacturers | 138 | 4 | 2 | |
| Off-trade | 122 | 3 | 0 | |
| On-trade | 577 | 18 | 3 | |
| Total | 2,592 | 200 | 141 |
To ask the Secretary of State for Health what estimates have been made for the annual costs that would be incurred by local authorities under the policy options published as part of Safe, Sensible, Social—Consultation on Further Action Impact Assessments.
To ask the Secretary of State for Health what estimates have been made for the annual costs that would be incurred by local authorities under the policy options published as part of Safe, Sensible, Social—Consultation on Further Action Impact Assessments.
To ask the Secretary of State for Health what research he has (a) commissioned and (b) evaluated in support of the 10 per cent. target for reduction in alcohol consumption mentioned in his Department's impact assessment relating to the Government's alcohol strategy.
To ask the Secretary of State for Health what research he has (a) commissioned and (b) evaluated in support of the 10 per cent. target for reduction in alcohol consumption mentioned in his Department's impact assessment relating to the Government's alcohol strategy.
To ask the Secretary of State for Health (1) how many consultation postcards were issued to the public in his Department's recent consultation on alcohol strategy;
To ask the Secretary of State for Health (1) how many consultation postcards were issued to the public in his Department's recent consultation on alcohol strategy;